Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2005
07/20/2005CN1211122C Heat-resisting lyophilized protectant for swine fever lapinized hyoptoxicity calf testicular cell vaccine and preparing process
07/20/2005CN1211121C Quadrivalent combination vaccine including diphtheria toxoid, tetanus toxoid, whole cell pertussis and hepatitis B surface antigen, and prepn. method thereof
07/20/2005CN1211117C Preparation of Xinxue granules
07/20/2005CN1211113C Instant preparation for easy to release symptom of SARS and its prepn. method
07/20/2005CN1211101C Formulation and preparing process of medicinal particle for treating viral carditis
07/20/2005CN1211096C Ready made Chinese medicine for treating pelvic infection and its production process
07/20/2005CN1211094C Medicine for treating pulmonary tuberculosis
07/20/2005CN1211093C Powder prepared from snake tissues for soaking feet
07/20/2005CN1211089C Application of uridine phosphorylase inhibitor and composition containing the same
07/20/2005CN1211085C Compositions having improved stability
07/20/2005CN1211071C Bathing disinfecting health-care preparation
07/20/2005CN1211063C Compositions comprising organosiloxane resins for delivering oral care substances
07/20/2005CN1211058C Container for oxazolidone intravenous solution and method for preventing loss of oxazolidone
07/19/2005US6919449 Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds
07/19/2005US6919432 Substances and their uses
07/19/2005US6919423 A 2-thiazole-4-(pyrrole-3yl)-oxo-7-methoxyquinoline derivatives, a protease enzyme inhibitors, for treating viral disease
07/19/2005US6919355 Amide derivatives as NMDA receptor antagonists
07/19/2005US6919353 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents
07/19/2005US6919352 Viricide against herpes virus
07/19/2005US6919351 Aza-and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
07/19/2005US6919347 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
07/19/2005US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
07/19/2005US6919340 Kinase moderators; controlling gene expression; immunosuppressants; autoimmune disease; rheumatic disorders; skin disorders; antitumor agents; anticancer agents
07/19/2005US6919335 Heterocycles that are inhibitors of IMPDH enzyme
07/19/2005US6919332 Enzyme inhibitors such as 5-(2-Methoxy-ethyl)-5-(4-(1-pyridin -3-yl-1H-indazol-5-yloxy)-phenoxy)-pyrimidine-2,4,6-trione, used as antiinflammatory and anticarcinogenic agents
07/19/2005US6919329 Microorganisms; bactericides; human and veterinary medicine
07/19/2005US6919327 Texaphyrin coordination compounds and uses thereof
07/19/2005US6919317 For therapy of diseases involving fungal or suspected fungal infection, for immunomodulation or immunosuppression in conditions in which fungal or suspected fungal colonisation of e.g.skin plays a role
07/19/2005US6919307 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
07/19/2005US6919206 Medium containing flt3 ligand for culturing hematophoietic cells
07/19/2005US6919085 E2 subunit vaccine comprising recombinant pestivirus E2 protein
07/19/2005US6919084 Antigen strain in vehicle; inducting immunology response
07/19/2005US6919080 Polypeptide for use in the treatment of respiratory disorders in poultry
07/14/2005WO2005064008A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
07/14/2005WO2005063740A1 Chrysogenazine obtained from fungus penicillium chrysogenum having antibacterial activity
07/14/2005WO2005063283A1 Vaccine comprising recombinant clpp protein of streptococcus pneumoniae
07/14/2005WO2005062882A2 Rifamycin analogs and uses thereof
07/14/2005WO2005062748A2 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae
07/14/2005WO2005037187A3 High affinity ligands for influenza virus and methods for their production
07/14/2005WO2005013955A8 Topical composition comprising terbinafine and hydrocortisone
07/14/2005WO2005009480A3 Implants containing codrugs
07/14/2005WO2004058285A8 Method for producing a biologically active substance
07/14/2005WO2004000016A9 Antimicrobial compositions, products and methods employing same
07/14/2005WO2003059294A3 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
07/14/2005WO2003029424A3 Novel proteins and nucleic acids encoding same
07/14/2005US20050154165 Ph-sensitive polymer
07/14/2005US20050154049 Administering an ultrasonic contrast agent; imaging tissue; medical diagnosis
07/14/2005US20050154045 E.g., N-[4-(2-Thienyl)phenyl]-1-azabicyclo[2.2.2]octane-3-carboxamide hydrochloride; treatment of impairments of perception, concentration, learning and/or memory
07/14/2005US20050154040 Nitrogen-containing heteroaryl derivatives
07/14/2005US20050154016 Preventives for hiv infection
07/14/2005US20050154012 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
07/14/2005US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition
07/14/2005US20050154003 Containing a 1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinoline ring, e.g., {10-[(E)-(ter-butoxyimino)methyl]-3-ethyl-1,13-dioxo-11,13-dihydro-1H,3H-furo[3',4':6,7]indolizino[1,2-b]quinolin-3-yl}acetic acid; topoisomerase I inhibitors used to treat cancer
07/14/2005US20050153995 Nonnucleoside inhibitors of reverse transcriptase, composite binding pocket and methods for use thereof
07/14/2005US20050153987 Compounds
07/14/2005US20050153973 (4R)-3-(2-{[8-(2-Pyrimidinyl)-8-azabicyclo[3.2.1]oct-3-yl]exo-amino}acetyl)thiazolidine-4-carbonitrile; enzyme inhibitors; diabetes
07/14/2005US20050153960 Substituted arylamine derivatives and methods of use
07/14/2005US20050153950 Broad -spectrum cephem compounds
07/14/2005US20050153943 Administering to mammal an effective amount of an anti-mucositis and anti-fungal pharmaceutical composition consisting of a tetracycline compound; no antibiotic activity
07/14/2005US20050153938 Polyphosphonate derivatives for toothpaste compositions
07/14/2005US20050153920 Ribozymes used as prodrugs
07/14/2005US20050153912 Antiviral oligonucleotides targeting viral families
07/14/2005US20050153910 Antibody and inhibitor and transformation method and transformation kit using the same
07/14/2005US20050153906 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy
07/14/2005US20050153905 antibacterial activity in humans and mammals; semi-synthetic
07/14/2005US20050153902 Inhibitors of integrin avb6
07/14/2005US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects
07/14/2005US20050153876 Compositions of lipopeptide antibiotic derivatives and methods of use thereof
07/14/2005US20050153871 Administering N-hydroxy-N-(4-butyl-2-methylphenyl)-formamidine (HET0016) to increase or prevent a decrease in cerebral blood flow
07/14/2005US20050153415 Lysin for use as tool in prevention of clostridial infection
07/14/2005US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders
07/14/2005US20050153057 Lipopolysaccharide for influenza vaccines and respiratory system disorders
07/14/2005US20050153018 pellets comprising compacted inner matrices containing viable microorganisms and moisture barrier coatings
07/14/2005US20050152985 The use of Colostrinin as a medicament, particularly in the treatment of chronic disorders of the central nervous system and the immune system.
07/14/2005US20050152975 Pharmaceutical composition
07/14/2005US20050152959 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
07/14/2005US20050152921 Modified CpG oligodeoxynucleotide with improved immunoregulatory function
07/14/2005US20050152920 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof
07/14/2005US20050152919 Measles virus antigens with a Proteosome-based adjuvant; treating or preventing a measles virus infection
07/14/2005US20050152917 Fusion protein for use in the treatment of viral diseases
07/14/2005US20050152915 Exposure of tumor cells obtained ex vivo or pathological cells of a non-tumorous nature or of a biological fluid of a mammal containing viruses or bacteria to radiation of the optical range, the administering them into the lymphatic system ; enhances the efficacy and usability of immunotherapy
07/14/2005US20050152910 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same
07/14/2005US20050152875 administering interferon- beta (IFN- beta ) before organ grafting or surgery, for the prophylaxis of viral diseases such as hepatitis
07/14/2005US20050152874 Unblocking immunization at a regional lymph node by: promoting differentiation and maturation of immature dendritic cells in a regional lymph node and; allowing presentation by resulting mature dendritic cells of antigen to T-cells
07/14/2005CA2551602A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity
07/14/2005CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds
07/14/2005CA2550729A1 Rifamycin analogs and uses thereof
07/14/2005CA2550309A1 Canine probiotic bifidobacteria pseudolongum
07/14/2005CA2550307A1 Canine probiotic bifidobacteria globosum
07/13/2005EP1553168A2 Methods for selectively stimulating proliferation of T cells
07/13/2005EP1553098A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient
07/13/2005EP1553084A1 Piperidine derivative, process for producing the same, and use
07/13/2005EP1552842A1 Bicyclic pyrimidine derivatives
07/13/2005EP1552018A2 Methods and compositions relating to gene silencing
07/13/2005EP1551972A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
07/13/2005EP1551961A2 Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
07/13/2005EP1551872A2 G-protein coupled receptors
07/13/2005EP1551865A2 Hybrid molcules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
07/13/2005EP1551849A1 Tricyclic tetrahydroquinoline antibacterial agents
1 ... 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 ... 1798